You are here
48th European Association for the Study of the Liver 2013
48th European Association For the Study of the Liver (EASL) The International Liver Congress
More than 9,000 clinicians attended the 48th annual EASL meeting in Amsterdam from April 24 to 28, 2013. Research on the full range of liver diseases was presented, but news from clinical trial outcomes was dominated by phase 2 and 3 trials of rapidly emerging and highly efficacious treatments for viral hepatitis C. Highlights from outstanding studies are included in this report.